nanog (Bioss)
Structured Review

Nanog, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nanog/product/Bioss
Average 91 stars, based on 11 article reviews
Images
1) Product Images from "TC2N maintains stem cell-like characteristics to accelerate lung carcinogenesis by blockade of dual specificity protein phosphatase 3."
Article Title: TC2N maintains stem cell-like characteristics to accelerate lung carcinogenesis by blockade of dual specificity protein phosphatase 3.
Journal: Cell & bioscience
doi: 10.1186/s13578-025-01348-3
Figure Legend Snippet: Fig. 2 High TC2N expression represents the upregulated expression of stem cell markers in lung cancer, but not in normal lung. A Gene set enrichment analysis (GSEA) analysis of TCGA database revealed that TC2N was related to “LUNG CELL DIFFERENTIATION” process in lung cancer but not in normal lung. NES, Normalized Enrichment Score. B Cohort 1 showed that the protein expression of TC2N was associated to differentiation degree (well, moderately and poorly differentiated) of human lung tumor. Scale bar represent 100 μm. The P value was measured with Student’s t-tests. **P < 0.01, ***P < 0.001. C Cohort 2 verified that the protein expression of TC2N was associated to DD of human lung tumor. The P value was measured with Student’s t-tests. ***P < 0.001. D Kaplan–Meier and COX regression analyses showed that TC2N expression was associated with poor prognosis of lung cancer patients. E Survival analysis of TC2N expression in lung cancer patients with well tumor differentiation by Kaplan–Meier and COX regression analyses. F Survival analysis of TC2N expression in lung cancer patients with moderately tumor differentiation by Kaplan–Meier and COX regression analyses. G Survival analysis of TC2N expression in lung cancer patients with poorly tumor differentiation by Kaplan–Meier and COX regression analyses. H IHC evaluation of SOX2, OCT4 and NANOG expression in normal lung tissues of TC2N engineered mice without urethane exposure. Scale bar represent 100 μm. I IHC evaluation of SOX2, OCT4 and NANOG expression in lung tissues of TC2N engineered mice with urethane exposure. Scale bar represent 100 μm
Techniques Used: Expressing, Cell Differentiation
Figure Legend Snippet: Fig. 3 TC2N upregulates the CSC-like characteristics of lung cancer cells. A Gene set enrichment analysis (GSEA) analysis of TCGA database revealed that TC2N was related to “STEM CELL” relevant processes in lung cancer but not in normal lung. NES, Normalized Enrichment Score. B Cellular morphol ogy of adherent lung cancer cells (Ad) compared to spheroid-forming lung cancer cells (Sp). Scale bars represent 120 μm (upper). WB analysis of TC2N expression in adherent and spheroid‐forming lung cancer cells (lower). C WB analysis of SOX2, OCT4 and NANOG expression in stable lung cancer cells. D The sphere formation ability of lung cancer cells with TC2N overexpression (TC2N group) and knockdown (shRNA group) was compared to that of the negative control (NC group). Scale bars represent 120 μm. Mean ± SEM. (n = 3). The P value was measured with Student’s t-tests. *P < 0.05, **P < 0.01. E The expression of CSCs marker CD133 (APC) in lung cancer cells with ectopic expression of TC2N (NC, shRNA and TC2N groups) were analyzed by flow cytometry. Mean ± SEM. (n = 3). The P value was measured with Student’s t-tests. **P < 0.01, ***P < 0.001. F The proportion of side population cells in lung cancer cells with ectopic expression of TC2N (NC, shRNA and TC2N groups) were analyzed by flow cytometry. Mean ± SEM. (n = 3). The P value was mea sured with Student’s t-tests. **P < 0.01, ***P < 0.001. G Soft agar colony formation ability of spheroid‐forming lung cancer cells with ectopic expression of TC2N (NC, shRNA and TC2N groups). Mean ± SEM. (n = 3). The P value was measured with Student’s t-tests. **P < 0.01, ***P < 0.001. The cell experiments were repeated 3 times independently
Techniques Used: Expressing, Over Expression, Knockdown, shRNA, Negative Control, Marker, Flow Cytometry

